Pages that link to "Q28360379"

The following pages link to HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation (Q28360379):

Displaying 50 items.

• Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein (Q24294963) (← links)
• Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53 (Q24296943) (← links)
• Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses (Q24298153) (← links)
• The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins (Q24315710) (← links)
• Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins (Q24319993) (← links)
• Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex (Q24561609) (← links)
• Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites (Q28078631) (← links)
• Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin (Q28264728) (← links)
• Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche (Q28548445) (← links)
• The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. (Q33292139) (← links)
• Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association (Q34013630) (← links)
• Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation (Q34141231) (← links)
• The human papillomavirus E6 protein and its contribution to malignant progression (Q34468780) (← links)
• Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis (Q34980270) (← links)
• HPV E6 proteins target Ubc9, the SUMO conjugating enzyme (Q35012060) (← links)
• The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose (Q35098707) (← links)
• E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. (Q35140477) (← links)
• Putting into practice domain-linear motif interaction predictions for exploration of protein networks (Q35499747) (← links)
• Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses (Q35531181) (← links)
• Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. (Q35545566) (← links)
• E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein (Q35635180) (← links)
• The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity (Q35785399) (← links)
• The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy (Q35895297) (← links)
• Mechanisms of human papillomavirus-induced oncogenesis. (Q35915935) (← links)
• Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins (Q36064347) (← links)
• The PDZ1 and PDZ3 domains of MAGI-1 regulate the eight-exon isoform of the coxsackievirus and adenovirus receptor (Q36154812) (← links)
• Cell polarity proteins: common targets for tumorigenic human viruses (Q36409895) (← links)
• Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy. (Q36482809) (← links)
• MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells. (Q36546491) (← links)
• Human papilloma virus (HPV) and host cellular interactions (Q37169150) (← links)
• Human papillomaviruses, cervical cancer and cell polarity (Q37333627) (← links)
• Papillomavirus E6 proteins (Q37350446) (← links)
• Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment (Q37866083) (← links)
• HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells (Q38829702) (← links)
• Interaction of HPV E6 oncoproteins with specific proteasomal subunits (Q39090529) (← links)
• Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance (Q39559326) (← links)
• Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. (Q39605811) (← links)
• A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions (Q39625147) (← links)
• The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg (Q39869402) (← links)
• E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway (Q39917232) (← links)
• Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling (Q40044008) (← links)
• HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. (Q40308181) (← links)
• HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation (Q40513963) (← links)
• Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. (Q40589896) (← links)
• Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis (Q40607486) (← links)
• The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. (Q40740004) (← links)
• Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis (Q42276511) (← links)
• Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97. (Q42585009) (← links)
• Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice (Q42670506) (← links)
• Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1. (Q44081167) (← links)